Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Benign Hematology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Published in Benign Hematology

Journal Scan / Research · July 13, 2020

Apixaban vs Enoxaparin for Preventing Postoperative VTE in Women Undergoing Surgery for Gynecologic Malignant Neoplasm

JAMA Network Open

 

Additional Info

JAMA Network Open
Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial
JAMA Netw Open 2020 Jun 01;3(6)e207410, SR Guntupalli, A Brennecke, K Behbakht, A Tayebnejad, CA Breed, LM Babayan, G Cheng, AA Ramzan, LJ Wheeler, BR Corr, C Lefkowits, J Sheeder, K Matsuo, D Flink

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading